Search the Newsreel

HC Wainwright Issues Pessimistic Forecast for TRAX Earnings

HC Wainwright Issues Pessimistic Forecast for IPSC Earnings

Citius Pharmaceuticals GAAP EPS of -$0.34 misses by $0.09, revenue of $1.5M misses by $8.27M

* Citius Pharmaceuticals press release [https://seekingalpha.com/pr/20620155-citius-pharmaceuticals-inc-reports-fiscal-third-quarter-2026-financial-results-and-provides] (CTXR [https://seekingalpha.com/symbol/CTXR]): Q3 GAAP EPS of -$0.34 misses by $0.09. * Revenue of $1.5M misses by $8.27M. * Cash and cash equivalents of $17.0 million as of June 30, 2026. MORE ON CITIUS PHARMACEUTICALS * Seeking Alpha’s Quant …

Valaris, Kodiak Gas Services, SM Energy, Patterson-UTI, and Solaris Energy Infrastructure Shares Are Soaring, What You Need To Know

Valaris, Kodiak Gas Services, SM Energy, Patterson-UTI, and Solaris Energy Infrastructure Shares Are Soaring, What You Need To Know What Happened? A number of stocks jumped in the morning session after the price of crude oil climbed due to escalating geopolitical tensions in the …

Cognizant and Benchling Selected as Partners to Accelerate Kyowa Kirin's R&D

Transforming the Research Lifecycle Through Integrated Data Management, Advanced Automation, and AI-Driven Workflows TOKYO, Aug. 16, 2026 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced that it will support the introduction and implementation of Benchling, the AI platform for R&D at Tokyo Research Park and …

Patterson-UTI Energy (PTEN) Files ESOP Shelf Registration, Is The Stock Still Undervalued?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. ESOP shelf registration puts Patterson-UTI Energy stock in focus Patterson-UTI Energy (PTEN) has filed a US$296.803 million shelf registration for up to 28,900,000 …

Scribe Therapeutics (SCTX) Stock Analysis Report | Financials & Insights

What's Going On With Medicenna Therapeutics Corp Stock Sunday?

Viking Therapeutics, Inc. (VKTX) Stock Price, News, Quote & History

Will Broadridge’s (BR) Dividend Hike, Buyback, and Web3 Voting Push Change Its Tokenization and AI Narrative?

Top Forgent Power Solutions (FPS) Competitors 2026

BioMarin (BMRN) Is Up 5.6% After Raising 2026 Revenue Outlook and Filing ESOP Shelf Registration

Vanda Prepares BYSANTI Launch As Patent Protection Extends To 2044

Vanda Pharmaceuticals is set to launch BYSANTI in the second half of 2026 following FDA approval for bipolar I disorder and schizophrenia, with patent protection extending until May 2044. The company also reported strong Q2 Fanapt sales growth and has several late-stage pipeline readouts …

Widening Losses And Profitability Swing Might Change The Case For Investing In Monte Rosa Therapeutics (GLUE)

Monte Rosa Therapeutics (GLUE) reported widening net losses for Q2 and the first half of 2026, marking a significant shift from prior-year profitability. This financial downturn, with a net loss of US$87.9 million for the six-month period, deepens the investment risk, highlighting the company's …

Die Motorola-Solutions-Aktie legt nach starken Quartalszahlen und optimistischer Prognose weiter zu

Why Tarsus Pharmaceuticals (TARS) Is Up 6.8% After Raising XDEMVY 2026 Sales Guidance - And What's Next

Tarsus Pharmaceuticals (TARS) saw its stock rise by 6.8% after reporting strong second-quarter 2026 results and raising its 2026 XDEMVY net product sales guidance to US$685 million–US$705 million. This increase signals management's confidence in XDEMVY's commercial trajectory, though the company still faces risks associated …

Bicara Therapeutics (BCAX) Is Down 13.5% After Leadership Overhaul And ESOP Shelf Filing - Has The Bull Case Changed?

Chesapeake Utilities (CPK) Reaffirmed Guidance And Raised Its Dividend, Is It Fully Priced?

Dianthus Therapeutics (DNTH) Is Up 6.5% After Unveiling DNTH312 Amid Wider Q2 Losses

Johnson & Johnson Purchases New Stake in Rapport Therapeutics, Inc. $RAPP

State of Wyoming Purchases New Position in Kymera Therapeutics, Inc. $KYMR

The State of Wyoming acquired a new position of 11,780 shares in Kymera Therapeutics, Inc. (NASDAQ:KYMR) valued at approximately $1.35 million during the second quarter. This comes as Kymera reported stronger-than-expected quarterly results with a significant revenue increase, although insiders sold a substantial amount …

S&CO Inc. Invests $6.40 Million in Revolution Medicines, Inc. $RVMD

S&CO Inc. recently invested $6.4 million in Revolution Medicines, Inc. (NASDAQ:RVMD) by purchasing 34,171 shares, contributing to institutional ownership of 94.34%. Despite a larger-than-expected quarterly loss, analysts maintain a "Moderate Buy" rating with a consensus price target of $161.79. Insider transactions show mixed activity, …

State of Wyoming Buys Shares of 9,446 Revolution Medicines, Inc. $RVMD

The State of Wyoming recently acquired 9,446 shares of Revolution Medicines, Inc. (NASDAQ:RVMD) valued at approximately $1.77 million, marking a new position in the biopharmaceutical company. This move comes as institutional investors and hedge funds collectively hold 94.34% of RVMD's stock. Despite a recent …

BioMarin Pharmaceutical (BMRN) Updates Guidance And Files Shelf Registration, Is It Still Below Fair Value?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. BioMarin Pharmaceutical (BMRN) has just given investors a packed update, including second quarter 2026 results, fresh earnings guidance for the rest of the …

Stoneridge Investment Partners LLC Invests $910,000 in Broadridge Financial Solutions, Inc. $BR

Stoneridge Investment Partners LLC has acquired a new position in Broadridge Financial Solutions, Inc. (NYSE:BR), purchasing 5,909 shares valued at approximately $910,000. Broadridge exceeded its quarterly earnings and revenue expectations, reporting $3.82 EPS and $2.22 billion in revenue, an increase of 7.5% year-over-year. The …

Ocular Therapeutix (OCUL) Is Up 9.2% After Wider Q2 Loss and New US$81.7M Shelf Registration

USA Financial Formulas Acquires New Position in Regeneron Pharmaceuticals, Inc. $REGN

USA Financial Formulas has acquired a new stake in Regeneron Pharmaceuticals (NASDAQ:REGN), purchasing 1,457 shares valued at approximately $1.13 million, making it their 27th-largest portfolio holding. Institutional investors collectively own 83.31% of Regeneron, with several major firms significantly increasing their positions. The company recently …

23,257 Shares in Corcept Therapeutics Incorporated $CORT Purchased by GSA Capital Partners LLP

GSA Capital Partners LLP recently acquired a new position of 23,257 shares in Corcept Therapeutics Incorporated (NASDAQ:CORT) during the second quarter, valued at approximately $2.022 million. Other institutional investors have also adjusted their holdings in CORT, with 93.61% of the stock owned by hedge …

Is Jacobs Solutions (J) Undervalued Following Its Utah Project Win And Mixed Earnings?

Is Ionis Pharmaceuticals (IONS) Undervalued Following Its Pullback?

BioLife Solutions, Inc. (NASDAQ:BLFS) Given Average Recommendation of "Hold" by Brokerages

BioLife Solutions (NASDAQ:BLFS) has received an average "Hold" recommendation from brokerages, with the majority of analysts issuing a hold rating. The company recently reported strong quarterly earnings, beating analyst estimates for both EPS and revenue. Despite positive institutional investor activity, insiders have sold a …

Emergent Biosolutions Inc. (NYSE:EBS) Given Average Rating of "Hold" by Analysts

Emergent Biosolutions Inc. (NYSE:EBS) has received an average "Hold" rating from analysts, with an average 12-month price target of $10.00. The company recently reported better-than-expected quarterly EPS of $0.60 and revenue of $234.3 million, though it posted a negative net margin and analysts anticipate …

Empowered Funds LLC Buys 25,775 Shares of MACOM Technology Solutions Holdings, Inc. $MTSI

Empowered Funds LLC significantly increased its stake in MACOM Technology Solutions Holdings, Inc. (MTSI) by 282.5% in Q1 2026, acquiring an additional 25,775 shares, bringing its total to 34,898 shares valued at $7.75 million. This comes as institutional investors and hedge funds own a …